Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs)

Keyphrases

• In Cancer 100%
• Cancer Treatment 100%
• Protein Tyrosine Phosphatase 1B (PTP1B) 100%
• SH2 Domain 100%
• Tyrosine Phosphatase Inhibitor 100%
• Tyrosine Kinase 60%
• Phosphatase 40%
• Malignancy 20%
• Drug Target 20%
• Tumor Progression 20%
• Target Molecule 20%
• Novel Therapeutics 20%
• Deregulation 20%
• Signal Transduction Pathway 20%
• Oncogenesis 20%
• Concerted Action 20%
• Signal Regulatory Protein α (SIRPα) 20%
• Progressive Effort 20%
• New Targeted Drugs 20%
• Protein Tyrosine Phosphorylation 20%
• SHP-1 20%
• SHP2 20%
• Cellular Signaling 20%
• Human Pathology 20%

Biochemistry, Genetics and Molecular Biology

• Protein Tyrosine Phosphatase 100%
• SH2 Domain 100%
• Receptor Tyrosine Kinase 50%
• Signal Transduction 33%
• Phosphatase 33%
• Tumor Progression 16%
• Carcinogenesis 16%
• Drug Targeting 16%
• Signal-Regulatory Protein Alpha 16%
• Tyrosine Phosphorylation 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Protein Tyrosine Phosphatase 100%
• Protein Tyrosine Kinase 50%
• Tumor Growth 16%
• Drug Delivery System 16%
• Carcinogenesis 16%
• Phosphatase 16%
• Protein Tyrosine Phosphatase SHP 1 16%
• Regulator Protein 16%